Jefferies Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$46.7K Hold
10,000
﹤0.01% 1514
2022
Q2
$59.2K Buy
10,000
+563
+6% +$6.27K ﹤0.01% 1387
2022
Q1
$182K Sell
9,437
-13,704
-59% -$314K ﹤0.01% 1282
2021
Q4
$756K Buy
+23,141
New +$931K ﹤0.01% 1075
2021
Q3
Sell
-336
Closed -$12.2K 1822
2021
Q2
$12.1K Buy
+336
New +$12.4K ﹤0.01% 1592
2021
Q1
Sell
-14,058
Closed -$632K 1763
2020
Q4
$567K Buy
+14,058
New +$646K ﹤0.01% 1090

Other funds holding GDRX

Jefferies Group's GDRX Position: Q3 2022 in Review

Jefferies Group held its GoodRx Holdings (GDRX) position steady in Q3 2022 at 10,000 shares worth $46.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1514.

Jefferies Group first reported a position in GDRX in Q4 2020 and has held it in 6 quarters since. The position peaked at $756K in Q4 2021. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

  • Jefferies Group held 10,000 shares of GoodRx Holdings worth $46.7K as of Q3 2022.
  • Jefferies Group left its GoodRx Holdings share count unchanged in Q3 2022.
  • GoodRx Holdings made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1514 holding.
  • Jefferies Group first reported a position in GoodRx Holdings in Q4 2020 and has held it in 6 quarters since.
  • Jefferies Group's GoodRx Holdings position peaked at $756K in Q4 2021.
  • 180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.